Beta-blockers antagonize beta-1 and beta-2 receptors which are the usual targets of the sympathetic nervous system, including epinephrine and norepinephrine. This results in a decreased heart rate ...
TCT 564: Efficacy and Safety of Myosin Inhibitors for Hypertrophic Obstructive Cardiomyopathy – An Updated Meta-Analysis of Randomized Controlled Trials Receive the the latest news, research, and ...
MADRID, Spain—Two randomized, controlled trials testing beta-blockers in post-MI patients without heart failure or impaired left ventricular ejection fraction added a bit of confusion to a field ...
Please provide your email address to receive an email when new articles are posted on . Beta-blockers have traditionally been prescribed for chronic coronary syndromes. Recent guidelines have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback